
    
      The purpose of this study is to evaluate the effect of vonoprazan on sleep disturbance in the
      participants under maintenance treatment for reflux esophagitis with proton pump inhibitor
      (PPI) other than vonoprazan after initial treatment.

      Participants who have been diagnosed as reflux esophagitis based on Los Angeles (LA)
      Classification Grades A to D, undergoing maintenance treatment with PPI other than vonoprazan
      after initial treatment, and with Pittsburgh Sleep Quality Index (PSQI) global score >= 6.0
      at enrolment (VISIT 1) will be eligible for study entry and will be administered vonoprazan
      20 mg once daily for 8 weeks.

      Planned number of participants is 25. The study period is 9 weeks. The number of visits is
      6visits.
    
  